2036 - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
78881284
Word Mark
2036
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2008-04-24
Filing Date
2006-05-11
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2007-07-31
Attorney Name
Law Office Assigned Location Code
L20
Employee Name
BAKER, JORDAN A
Statements
Goods and Services
Pharmaceutical, veterinary, and sanitary preparations, all used for the treatment of infectious diseases, namely, respiratory infections, eye infections, for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, for the treatment of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, for use in ophthalmology, for the treatment of dental and oral diseases, for use in gastroenterology; for the treatment of the respiratory system, for use in ocular disorders, for the treatment of cardiovascular diseases, acne medication, allergy medication, antacids, anthelmintics, anti-arrhythmics, antibiotic creams and ointments, antibiotics, anticoagulants, anticonvulsants, antidepressants, antiemetics, antiflatulants, antihistamines, antihypertensives anti-infectives, anti-inflammatories, antiparasites, antivirals, burn relief medications, calcium channels blockers, central nervous system depressants, central nervous system stimulants, cough treatment medication, diarrhea medication, fungal medications, gastro-intestinal pharmaceutical preparations, glaucoma agents, hydrocortisone, hypnotic agents, sedatives; dietetic substances, namely foods, adapted for medical use; vitamin supplements, mineral food supplements; herbal extracts for medical purposes; medicated extracts of plants and herbs in the form of capsules, tablets, liquid concentrate, powder, and crystals; dietetic supplements for medical use and nutritious health food supplement for medical use all made primarily of lingzhi spores, lingzhi spore lipids, yunzhi, bee glue or propolis, or cordyceps or extracts therefrom; lingzhi granules, lingzhi pills, lingzhi capsules, lingzhi tablets; and medicinal tea made primarily of lingzhi spores; Chinese herbal medicines, and Chinese patent medicines all composed of lingzhi spores, lingzhi spore lipids, yunzhi, bee glue, propolis, or cordyceps, and used for the treatment of infectious diseases, namely, respiratory infections, eye infections, for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases, for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, for the treatment of neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, for the treatment of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, for use in ophthalmology, for the treatment of dental and oral diseases, for use in gastroenterology, for the treatment of the respiratory system, for use in ocular disorders, for the treatment of cardiovascular diseases, acne medication, allergy medication, antacids, anthelmintics, anti-arrhythmics, antibiotic creams and ointments, antibiotics, anticoagulants, anticonvulsants, antidepressants, antiemetics, antiflatulants, antihistamines, antihypertensives anti-infectives, anti-inflammatories, antiparasites, antivirals, burn relief medications, calcium channels blockers, central nervous system depressants, central nervous system, stimulants, cough treatment medication, diarrhea medication, fungal medications, gastro-intestinal pharmaceutical preparations, glaucoma agents, hydrocortisone, hypnotic agents, sedatives
Pseudo Mark
TWO THOUSAND THIRTY-SIX
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2006-05-17
Primary Code
005
Correspondences
Name
JOHN CLARKE HOLMAN
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2006-05-17 | NEW APPLICATION ENTERED IN TRAM |
2006-06-26 | TEAS VOLUNTARY AMENDMENT RECEIVED |
2006-06-26 | APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED |
2006-10-14 | ASSIGNED TO EXAMINER |
2006-10-16 | NON-FINAL ACTION WRITTEN |
2006-10-16 | NON-FINAL ACTION MAILED |
2007-04-09 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2007-04-09 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2007-04-10 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2007-04-12 | EXAMINERS AMENDMENT -WRITTEN |
2007-04-12 | EXAMINER'S AMENDMENT ENTERED |
2007-04-12 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2007-04-12 | EXAMINERS AMENDMENT MAILED |
2007-05-02 | ASSIGNED TO LIE |
2007-05-10 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2007-07-11 | NOTICE OF PUBLICATION |
2007-07-31 | PUBLISHED FOR OPPOSITION |
2007-10-23 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
2008-06-25 | ABANDONMENT - NO USE STATEMENT FILED |
2008-06-25 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |